Work

Mo2037 USTEKINUMAB IN DEVELOP: A SAFETY ANALYSIS FROM AN INFLAMMATORY BOWEL DISEASE MULTICENTER, PROSPECTIVE, LONG-TERM REGISTRY OF PEDIATRIC PATIENTS

Year: 2024

Type: conference-abstract

Source: Gastroenterology

DOI: 10.1016/s0016-5085(24)03229-3

Authors: Sibylle Koletzko, Gigi Veereman, Jeffrey S. Hyams, Marla C. Dubinsky, Bridget Godwin, Christopher Busse, Richard Strauss, Sheri Volger, Yanli Wang, Anne M. Griffiths, Richard B. Colletti, Subra Kugathasan, James Markowitz, Winter Harland, Johanna C. Escher, Robert N. Baldassano, Frank Ruemmele, William Faubion, Benjamin D. Gold

Language: English

Topic: Inflammatory Bowel Disease

Subfield: Genetics

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4396644214

Cites:

Cited by:

Related to: 10